Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Human thymoma-associated mutation of the GTF2I transcription factor impairs thymic epithelial progenitor differentiation in mice.

Tytuł:
Human thymoma-associated mutation of the GTF2I transcription factor impairs thymic epithelial progenitor differentiation in mice.
Autorzy:
Giorgetti OB; Department of Developmental Immunology, Max Planck-Institute of Immunobiology and Epigenetics, Stuebeweg 51, D-79108, Freiburg, Germany.
Nusser A; Department of Developmental Immunology, Max Planck-Institute of Immunobiology and Epigenetics, Stuebeweg 51, D-79108, Freiburg, Germany.
Boehm T; Department of Developmental Immunology, Max Planck-Institute of Immunobiology and Epigenetics, Stuebeweg 51, D-79108, Freiburg, Germany. .; Faculty of Medicine, University of Freiburg, Breisacher Str. 153, D-79110, Freiburg, Germany. .
Źródło:
Communications biology [Commun Biol] 2022 Sep 29; Vol. 5 (1), pp. 1037. Date of Electronic Publication: 2022 Sep 29.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: London, United Kingdom : Nature Publishing Group UK, [2018]-
MeSH Terms:
Thymoma*/genetics
Thymus Neoplasms*/genetics
Transcription Factors, General*
Transcription Factors, TFII*/genetics
Transcription Factors, TFIII*
Animals ; Humans ; Mice ; Mice, Transgenic ; Mutation ; Receptors, Antigen, T-Cell ; Transcription Factors
References:
Nature. 2006 Jun 22;441(7096):992-6. (PMID: 16791198)
Bioinformatics. 2014 Apr 1;30(7):923-30. (PMID: 24227677)
Gene Expr Patterns. 2006 Oct;6(8):794-9. (PMID: 16517216)
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544. (PMID: 29790989)
Genome Biol. 2014;15(12):550. (PMID: 25516281)
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7517-22. (PMID: 21502490)
J Neurol. 2013 Jul;260(7):1798-801. (PMID: 23508539)
Cancer Cell. 2018 Feb 12;33(2):244-258.e10. (PMID: 29438696)
Cell. 2012 Mar 30;149(1):159-72. (PMID: 22464328)
Cancers (Basel). 2020 Jul 24;12(8):. (PMID: 32722121)
Development. 2020 Jun 22;147(12):. (PMID: 32467240)
J Immunol. 2005 Oct 15;175(8):5213-21. (PMID: 16210626)
Nature. 2022 Jun;606(7912):165-171. (PMID: 35614226)
Nat Protoc. 2009;4(1):44-57. (PMID: 19131956)
Lung Cancer. 2017 Aug;110:48-52. (PMID: 28676218)
Nat Genet. 2013 Nov;45(11):1361-5. (PMID: 24097066)
Sci Rep. 2017 Sep 4;7(1):10314. (PMID: 28871142)
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5742-6. (PMID: 8650163)
Eur J Immunol. 2013 Sep;43(9):2507-15. (PMID: 23696157)
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3463-8. (PMID: 22331880)
Science. 1996 May 10;272(5263):886-9. (PMID: 8629026)
Development. 2020 Jun 22;147(12):. (PMID: 32467237)
Clin Dev Immunol. 2006 Jun-Dec;13(2-4):299-319. (PMID: 17162372)
Neural Regen Res. 2019 Feb;14(2):346-353. (PMID: 30531019)
Cell Death Differ. 2020 Jul;27(7):2263-2279. (PMID: 32034314)
Annu Rev Immunol. 2008;26:355-88. (PMID: 18304000)
Clin Exp Rheumatol. 2015 Sep-Oct;33(5):632-8. (PMID: 26320362)
J Clin Pathol. 2021 Feb;74(2):84-90. (PMID: 32467319)
Nucleic Acids Res. 2009 Jan;37(1):1-13. (PMID: 19033363)
Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886)
Pathol Int. 1994 May;44(5):359-67. (PMID: 8044305)
Nat Rev Immunol. 2013 Nov;13(11):831-8. (PMID: 24052146)
Sci Adv. 2021 Jan 1;7(1):. (PMID: 33523858)
Nat Genet. 2014 Aug;46(8):844-9. (PMID: 24974848)
Front Immunol. 2021 Jun 23;12:640083. (PMID: 34248934)
J Thorac Oncol. 2022 Feb;17(2):200-213. (PMID: 34695605)
Sci Adv. 2020 Nov 27;6(48):. (PMID: 33246964)
J Immunol. 2013 Aug 1;191(3):1200-9. (PMID: 23794633)
J Exp Med. 2002 May 20;195(10):1349-58. (PMID: 12021314)
Nat Rev Immunol. 2020 Apr;20(4):239-253. (PMID: 31804611)
Mol Cell. 2006 Oct 20;24(2):301-8. (PMID: 17052463)
Nature. 2007 Aug 23;448(7156):934-7. (PMID: 17687331)
Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16613-8. (PMID: 20823228)
Nat Immunol. 2007 Mar;8(3):304-11. (PMID: 17277780)
Nature. 2018 Jul;559(7715):627-631. (PMID: 30022164)
Sci Rep. 2016 Jun 08;6:27563. (PMID: 27272985)
Cell. 2009 Jul 10;138(1):186-97. (PMID: 19559469)
Int Immunol. 2021 Jul 23;33(8):423-434. (PMID: 34036345)
Substance Nomenclature:
0 (GTF2I protein, human)
0 (Gtf2i protein, mouse)
0 (Receptors, Antigen, T-Cell)
0 (Transcription Factors)
0 (Transcription Factors, General)
0 (Transcription Factors, TFII)
0 (Transcription Factors, TFIII)
Entry Date(s):
Date Created: 20220929 Date Completed: 20221003 Latest Revision: 20221006
Update Code:
20240105
PubMed Central ID:
PMC9522929
DOI:
10.1038/s42003-022-04002-7
PMID:
36175547
Czasopismo naukowe
Few human tumours present with a recurrent pathognomonic mutation in a transcription factor. Thymomas are an exception, with the majority of some subtypes exhibiting a distinct somatically acquired missense mutation in the general transcription factor GTF2I. Co-dominant expression of wild-type and mutated forms of Gtf2i in the mouse thymic epithelium is associated with aberrant thymic architecture and reduced thymopoietic activity. Phenotypic and molecular characterization of the mutant epithelium indicates that medullary differentiation is particularly affected as a result of impaired differentiation of bi-potent epithelial progenitors. The resulting gene expression signature is dominated by that of immature cortex-like thymic epithelial cells. TCR repertoire analysis of the cytopenic T cell compartment indicates efficient intrathymic selection; hence, despite marked homeostatic proliferation of T cell clones, autoimmunity is not observed. Thus, our transgenic mouse model recapitulates some aspects of the pathophysiology of a genetically defined type of human thymoma.
(© 2022. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies